Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pathology
Volume 2015 (2015), Article ID 135684, 6 pages
http://dx.doi.org/10.1155/2015/135684
Case Report

Occult Breast Lobular Carcinoma with Numerous Circulating Tumor Cells in Peripheral Blood

1Department of Diagnostic Pathology, Juntendo University Nerima Hospital, Tokyo 177-8521, Japan
2Department of Radiology, Juntendo University Nerima Hospital, Tokyo 177-8521, Japan
3Department of Breast Surgery, Juntendo University Nerima Hospital, Tokyo 177-8521, Japan

Received 2 April 2015; Revised 20 May 2015; Accepted 4 June 2015

Academic Editor: Janina Kulka

Copyright © 2015 Kanako Ogura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. C. Pestalozzi, D. Zahrieh, E. Mallon et al., “Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials,” Journal of Clinical Oncology, vol. 26, no. 18, pp. 3006–3014, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. S. Moran, Q. Yang, and B. G. Haffty, “The yale university experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology,” The Breast Journal, vol. 15, no. 6, pp. 571–578, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. R. Lakhani, E. Rakha, and P. T. Simpson, “Invasive lobular carcinoma,” in WHO Classification of Tumours of the Breast, S. R. Lakhani, I. O. Ellis, S. J. Schnitt, P. H. Tan, and M. J. van de Vijver, Eds., pp. 40–42, IARC, 4th edition, 2012. View at Google Scholar
  4. H. G. Kopp, K. Krauss, T. Fehm et al., “Symptomatic bone marrow involvement in breast cancer—clinical presentation, treatment and prognosis: a single institution review of 22 cases,” Anticancer Research, vol. 24, pp. 1593–1599, 2009. View at Google Scholar
  5. S. Lanitis, K. A. Behranwala, R. Al-Mufti, and D. Hadjiminas, “Axillary metastatic disease as presentation of occult or contralateral breast cancer,” Breast, vol. 18, no. 4, pp. 225–227, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Pentheroudakis, G. Lazaridis, and N. Pavlidis, “Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidence,” Breast Cancer Research and Treatment, vol. 119, no. 1, pp. 1–11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Neal, N. Sookhan, and C. Reynolds, “Occult breast carcinoma presenting as gastrointestinal metastases,” Case Reports in Medicine, vol. 2009, Article ID 564756, 3 pages, 2009. View at Publisher · View at Google Scholar
  8. L. Fortunato, A. Mascaro, A. Baldi et al., “Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer,” Annals of Surgical Oncology, vol. 16, no. 11, pp. 3010–3019, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. C. V. Cotta, S. Konoplev, L. J. Medeiros, and C. E. Bueso-Ramos, “Metastatic tumors in bone marrow: histopathology and advances in the biology of the tumor cells and bone marrow environment,” Annals of Diagnostic Pathology, vol. 10, no. 3, pp. 169–192, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. H. Lyda, M. Tetef, N. H. Carter, D. Ikle, L. M. Weiss, and D. A. Arber, “Keratin immunohistochemistry detects clinically significant metastases in bone marrow biopsy specimens in women with lobular breast carcinoma,” American Journal of Surgical Pathology, vol. 24, no. 12, pp. 1593–1599, 2000. View at Publisher · View at Google Scholar · View at Scopus